# Epigral Targets ₹5,000 Crore Revenue by FY31

> Epigral plans to double revenue to ₹5,000 crore by 2030-31 through CPVC Resin and ECH capacity expansions.
- Title: Epigral Targets ₹5,000 Crore Revenue by FY31 | Shortify
- Summary: Epigral plans to double revenue to ₹5,000 crore by 2030-31 through CPVC Resin and ECH capacity expansions. Epigral expects to reach ₹5,000 crore revenue by…
- Keywords: epigral, cpvc resin, epichlorohydrin, capacity expansion, revenue target, gujarat, import substitution, specialty chemicals, Targets, 000, Crore, Revenue
- Source: The Economic Times — https://economictimes.indiatimes.com/industry/indl-goods/svs/chem-/-fertilisers/capacity-scale-ups-to-drive-epigrals-rs-5000-crore-target-by-fy31-cmd-maulik-patel/articleshow/134518941.cms
- Author: PTI
- Published: 2026-09-27T11:17:00+00:00
- Read time: 1 min
- Topics: epigral, cpvc resin, epichlorohydrin, capacity expansion, revenue target, gujarat, import substitution, specialty chemicals
## Revenue Target
Epigral aims for ₹5,000 crore revenue by 2030-31, driven by CPVC Resin and Epichlorohydrin production scale-ups.

> In FY26, we ended with around Rs 2,500-2,530 crore of revenue, and at the current pace of growth, we expect around Rs 2,900 crore this financial year.
## Capacity Expansion Plans
CPVC Resin capacity doubles from 75,000 TPA to 150,000 TPA; ECH capacity doubles from 50,000 TPA to 100,000 TPA at Dahej, Gujarat units.

> Both capacity expansions are expected to be commissioned within a couple of months.
## Fiscal Year Revenue Projection
Epigral expects ₹2,900 crore revenue this fiscal year after ₹2,500-2,530 crore in FY26.

> In FY26, we ended with around Rs 2,500-2,530 crore of revenue, and at the current pace of growth, we expect around Rs 2,900 crore this financial year.
## Import Substitution Strategy
Epigral became India's largest CPVC resin producer and the first Indian company to manufacture ECH using renewable glycerine.

> To produce import-substitute chemicals, we became the first Indian company to manufacture ECH using a 100 per cent renewable glycerine-based process instead of the crude-oil-based propylene route used in the West, a deliberately greener product.
## New Chemistry Line
Epigral bought new land at Dahej for an entirely new chemistry line, still finalising a technology partner.

> We also started manufacturing CPVC resin and have already become India's largest producer; with the doubling of capacity, we will become the world's largest manufacturer in this category.
## Future Revenue Projections
Epigral expects to double revenue to ₹5,000 crore by 2030-31 through capacity expansions.

> Therefore, we are expecting to double our revenue to around Rs 5,000 crore by 2030-31.
## Key takeaway

Epigral expects to reach ₹5,000 crore revenue by FY31 via production scale-ups in CPVC Resin and Epichlorohydrin.